Product Information
CITALOPRAM HBR 10 MG/5 ML SOLN is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1795 per ML under NDC 00054006258. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 13, 2004. Its Orange Book therapeutic-equivalence code is AA.
Strength
10 mg/5mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054006258
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CITALOPRAM HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077043FDA Approved
12/13/2004
TE Code
AA
On Market Since
5/25/2004
Pharmacological Classes
Price Statistics
The NADAC for CITALOPRAM HBR 10 MG/5 ML SOLN has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 31.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1795 per ML |
|---|---|
| All-time high | $0.4246 (May 16, 2018) |
| All-time low | $0.1112 (May 22, 2024) |
| 52-week high | $0.2084 |
| 52-week low | $0.1688 |
| Median price | $0.2095 |
| Average price | $0.2124 |
| Largest weekly change | +68.0% (Mar 21, 2018) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Citalopram market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Citalopram market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CITALOPRAM HBR 10 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 10 MG/5 ML SOLN, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1795 per ML (NDC 00054006258), effective Sep 30, 2026.
How has the price of CITALOPRAM HBR 10 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for CITALOPRAM HBR 10 MG/5 ML SOLN has risen 31.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 10 MG/5 ML SOLN?
Since Nov 28, 2013, the NADAC for CITALOPRAM HBR 10 MG/5 ML SOLN has ranged from a low of $0.1112 (May 22, 2024) to a high of $0.4246 (May 16, 2018), with a median of $0.2095 per ML.
Are there cheaper alternatives to CITALOPRAM HBR 10 MG/5 ML SOLN?
No other NADAC-published product currently shares the active ingredient and strength of CITALOPRAM HBR 10 MG/5 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CITALOPRAM HBR 10 MG/5 ML SOLN?
CITALOPRAM HBR 10 MG/5 ML SOLN (NDC 00054006258) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.